State Street Corp Intellia Therapeutics, Inc. Transaction History

State Street Corp

$2.47 Trillion
Q4 2024

A detailed history of State Street Corp transactions in Intellia Therapeutics, Inc. stock. As of the latest transaction made, State Street Corp holds 5,205,698 shares of NTLA stock, worth $55.7 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

5,205,698

Previous 5,143,534 1.21%

Holding current value

$55.7 Million

Previous $106 Million 42.57%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$11.41 - $21.09 $709,291 - $1.31 Million	62,164 Added 1.21%	5,205,698 $60.7 Million
Q3 2024 Nov 14, 2024	BUY	$19.72 - $27.36 $15.4 Million - $21.4 Million	780,754 Added 17.9%	5,143,534 $106 Million
Q2 2024 Aug 14, 2024	SELL	$20.02 - $27.22 $4.71 Million - $6.4 Million	-235,042 Reduced 5.11%	4,362,780 $97.6 Million
Q1 2024 May 15, 2024	SELL	$23.82 - $32.8 $3.29 Million - $4.53 Million	-138,039 Reduced 2.91%	4,597,822 $126 Million
Q4 2023 Feb 14, 2024	BUY	$23.16 - $32.34 $23.2 Million - $32.4 Million	1,002,936 Added 26.87%	4,735,861 $144 Million
Q3 2023 Nov 14, 2023	BUY	$31.62 - $45.78 $7.59 Million - $11 Million	240,134 Added 6.88%	3,732,925 $118 Million
Q2 2023 Aug 14, 2023	SELL	$34.58 - $46.03 $1.62 Million - $2.16 Million	-46,847 Reduced 1.32%	3,492,791 $142 Million
Q1 2023 May 15, 2023	SELL	$33.3 - $44.82 $7.16 Million - $9.64 Million	-215,106 Reduced 5.73%	3,539,638 $132 Million
Q4 2022 Feb 14, 2023	BUY	$33.21 - $62.69 $35.4 Million - $66.9 Million	1,067,025 Added 39.7%	3,754,744 $131 Million
Q3 2022 Nov 15, 2022	SELL	$53.92 - $71.7 $24.6 Million - $32.7 Million	-456,092 Reduced 14.51%	2,687,719 $150 Million
Q2 2022 Aug 15, 2022	BUY	$38.49 - $76.21 $28.7 Million - $56.9 Million	746,284 Added 31.13%	3,143,811 $163 Million
Q1 2022 May 16, 2022	BUY	$58.27 - $118.99 $32.4 Million - $66.2 Million	556,076 Added 30.2%	2,397,527 $174 Million
Q4 2021 Feb 14, 2022	BUY	$100.76 - $138.36 $18.1 Million - $24.9 Million	179,721 Added 10.82%	1,841,451 $218 Million
Q3 2021 Nov 15, 2021	SELL	$132.37 - $176.78 $15.4 Million - $20.6 Million	-116,612 Reduced 6.56%	1,661,730 $223 Million
Q2 2021 Aug 16, 2021	SELL	$60.88 - $161.91 $3.06 Million - $8.14 Million	-50,297 Reduced 2.75%	1,778,342 $288 Million
Q1 2021 May 17, 2021	SELL	$46.59 - $83.68 $19.3 Million - $34.7 Million	-414,101 Reduced 18.46%	1,828,639 $147 Million
Q4 2020 Feb 16, 2021	SELL	$18.83 - $63.53 $15.4 Million - $51.8 Million	-815,858 Reduced 26.67%	2,242,740 $122 Million
Q3 2020 Nov 10, 2020	BUY	$17.47 - $24.93 $12.9 Million - $18.4 Million	739,310 Added 31.88%	3,058,598 $60.8 Million
Q2 2020 Aug 14, 2020	BUY	$11.14 - $22.87 $6.62 Million - $13.6 Million	594,605 Added 34.48%	2,319,288 $48.8 Million
Q1 2020 May 11, 2020	BUY	$9.44 - $15.58 $16.3 Million - $26.9 Million	1,724,683 New	1,724,683 $21.1 Million

Others Institutions Holding NTLA

# of Institutions

335

Shares Held

96.1M

Call Options Held

1.06M

Put Options Held

863K

View Full List

About Intellia Therapeutics, Inc.

Ticker NTLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,011,800
Market Cap $813M
Description
Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...

More about NTLA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Intellia Therapeutics, Inc. Transaction History